Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 595

Results For "GE"

7622 News Found

Govt clears 49 applicants for PLI in Bulk Drugs
News | March 30, 2022

Govt clears 49 applicants for PLI in Bulk Drugs

The selected 49 applications are from 33 companies. Out of these 33 companies, 13 are Micro, Small and Medium Enterprises (MSMEs) besides some newly incorporated entities


Medtronic commences PRAAN registry for stroke patients
Medical Device | March 30, 2022

Medtronic commences PRAAN registry for stroke patients

The registry will be conducted for approximately two and a half years and up to 200 subjects will be enrolled


OPPI summit calls for collaboration across stakeholders
News | March 30, 2022

OPPI summit calls for collaboration across stakeholders

The summit also saw the launch of two important reports- Multi-Regional Clinical Trials (MRCT) and Value of OTC in India


Sara Gutierrez joins SHL as the Chief Science Officer
People | March 30, 2022

Sara Gutierrez joins SHL as the Chief Science Officer

The science leader comes with a rich experience in the employment testing industry


NAMSA to acquire European-based Medanex clinic
Biotech | March 30, 2022

NAMSA to acquire European-based Medanex clinic

World-leading companies, as well as small innovative research groups, regularly partner with Medanex for their outstanding cardiovascular services and timely, efficacious study outcomes.


X-Chem’s Noor Shaker awarded for achievements in AI for drug discovery
News | March 30, 2022

X-Chem’s Noor Shaker awarded for achievements in AI for drug discovery

Shaker is one of six receiving an individual award, which recognizes people, organizations and products bringing AI to life and applying it to solve real problems


TDB approves funding for MIM in MedTech
News | March 30, 2022

TDB approves funding for MIM in MedTech

Technology Development Board supports commercialisation of Metal Injection Molding of implants


USFDA clears IND application for an intranasal RSV vaccine
Biotech | March 29, 2022

USFDA clears IND application for an intranasal RSV vaccine

The companies are now preparing to initiate a Phase 1 trial to assess the safety and immunogenicity of BLB-201 in healthy volunteers


USFDA approves EUA for second booster dose of Moderna
News | March 29, 2022

USFDA approves EUA for second booster dose of Moderna

50 µg dose approved for all adults over 50 years of age and immunocompromised adults over 18 years of age


Ozempic 2.0 mg approved in the US for the treatment of type 2 diabetes
Drug Approval | March 29, 2022

Ozempic 2.0 mg approved in the US for the treatment of type 2 diabetes

Ozempic is now approved in the US at 0.5 mg,1.0 mg and 2.0 mg doses for the treatment of type 2 diabetes in adults